Backed by decades of experience in medical device development and insights of the world’s top transcatheter valve therapy experts, VALFIX has created a revolutionary mitral valve repair system.
VALFIX’s proprietary technology was designed to fully convert open heart valve surgery into a transcatheter procedure.
Through our technology, we’re fulfilling our mission to alleviate heart failure symptoms, improve patient quality of life, and save lives.
Founder
CEO
Chairman of the Board
Founder
CEO
Chairman of the Board
Eli is a mechanical engineer, inventor, and serial entrepreneur who is responsible for more than 100 inventions and 50 patents. Eli has more than 25 years of expertise in medical device development and interventional cardiology and has unique experience in developing cardiac metallic implants and delivery systems. In his previous role as CTO at InspireMD, Eli orchestrated several class III device projects, taking them from concept to market. Eli excels in leading product development teams from concept through product design and clinical approvals to worldwide sales.
Founder
VP Clinical & Regulatory
Founder
VP Clinical & Regulatory
Prior to co-founding VALFIX, Elad was the Scientific Manager at Medtronic, a large multinational corporation. Elad has been VP Clinical Research at several SMEs, such as InspireMD, and has extensive experience working with clinicians in hospitals as well as providing clinical support to sales and marketing teams. With rich expertise in clinical trial design and execution, Elad is skilled in business development in the field of medical devices, Good Clinical Practice (GCP), biomedical engineering, and cardiology. He holds an MBA and MSc in Medical Physics.
Investor
Senior Biomedical Statistician
Investor
Senior Biomedical Statistician
Dr Philip Lavin is a senior biomedical statistician and an independent statistical consultant for clinical trial design, analysis, execution, and representation to regulatory, reimbursement, and legal agencies. Dr Lavin has over 35 years serving as an expert consultant with core expertise in biostatistics. Dr Lavin also an investor in the company.
Venture Capital Executive
Venture Capital Executive
As a Managing Partner for Ballast Capital, Evan is on several MedTech boards and operates the investment firm, Ballast Capital LLC. Prior to founding Ballast, he was a General Partner at Accelmed Partners and spent a decade leading Abbott Ventures. Prior to Abbott, Evan was a Principal with ONSET Ventures. He also worked for the Investment Banking Group at J.P. Morgan Chase & Co and at PriceWaterhouseCoopers. An adjunct professor at Kellogg, Evan serves on the Innovation and New Ventures Advisory Board and N.XT Fund investment committee at Northwestern University.
Investor
Interventional Cardiologist
Investor
Interventional Cardiologist
Dr Gary Gershony is a serial entrepreneur and an Interventional Cardiologist, board certified in both general cardiology and interventional cardiology. He is a Fellow of the American College of Cardiology, the Royal College of Physicians, the American Heart Association, and the Society for Cardiovascular Angiography and Interventions. Dr Gershony is the author of ten medical device patents. He is also an investor in the company.
Cardiothoracic Surgeon
Healthcare Consultant
Cardiothoracic Surgeon
Healthcare Consultant
Surin Mitruka, MD, MBA practiced adult cardiac, thoracic, and vascular surgery in the private sector as the Director of three surgical programs and Heart Institutes in California. He specialized in complex coronary revascularizations, and minimally invasive valve surgery. He is widely published, travelled extensively to lecture and demonstrate procedures for arrhythmia surgery, and served as a KOL for Medtronic. Previously, he Co-Founded a medical device company to a successful exit. Since retiring from clinical medicine, his current interests include consulting and advising, as well as entrepreneurial and leadership roles in the healthcare industry.
Founder
Chief Medical Officer
Interventional Cardiologist
Founder
Chief Medical Officer
Interventional Cardiologist
Dr Yaron Almagor is an interventional cardiologist and the Director of the Invasive Cardiology unit at Shaare Zedek Hospital in Jerusalem, Israel. He is one of the pioneers of interventional cardiology and a leading cardiologist in Israel. Dr Almagor is well known and respected in the international cardiology community and serves as an associate and co-director of the Columbus Heart Center in Milan. Dr Almagor has been instrumental in several development projects throughout his career that resulted in the market launch of several medical devices.
Chairman of the Board
Interventional Cardiologist
Chairman of the Board
Interventional Cardiologist
In addition to heading Academic Affairs at Mount Sinai, Dr Gregg Stone is Professor of Medicine and Population Health Sciences and Policy at Mount Sinai in New York. Dr Stone has served as principal investigator for approximately 100 national and international multi-center randomized trials and has authored more than 2,000 peer-reviewed publications. His areas of expertise include interventional therapies of acute coronary syndromes; transcatheter mitral valve repair and replacement; clinical trial design; and regulatory issues.
Interventional Cardiologist
Interventional Cardiologist
Dr Joachim Schofer is an internationally renowned interventional cardiologist at the MVZ Department for structural heart disease at Asklepios Clinic St. Georg in Hamburg, Germany. He is the recipient of multiple awards, authored more than 300 publications in high-ranking international journals, and given more than 1200 presentations at scientific conferences. A pioneer with over 15 years of experience in the percutaneous treatment of heart valve diseases and specialist in the treatment of the mitral and tricuspid valves.
Senior Regulatory Consultant
Senior Regulatory Consultant
Dr Semih Oktay is the President and founder of CardioMed Device Consultants. Dr Oktay worked for six years as an expert Mechanical Engineer and scientific reviewer for the U.S. Food and Drug Administration (FDA) in the Office of Device Evaluation, Interventional Cardiology Devices Branch. In this role he served as primary reviewer in the product areas of coronary stents, peripheral stents, and balloon angioplasty catheters. Dr Oktay holds a considerable and in-depth understanding of the fields of material science, medical devices, medical device regulations, and regulatory submission requirements.
Interventional Cardiologist
Interventional Cardiologist
Dr Martin Leon is a Professor of Cardiology at Columbia University Irving Medical Center and Director of the Center for Interventional Vascular Therapy (CIVT) at New York-Presbyterian/Columbia University Irving Medical Center. A distinguished pioneer in interventional cardiovascular medicine, Dr Leon has been the national principal investigator for over 50 clinical trials that helped shape the field. He has co-authored almost 2,000 peer-reviewed scientific publications and abstracts. As a practicing interventional cardiologist, Dr Leon has performed more than 10,000 procedures during his career.
Cardiac Surgeon
Cardiac Surgeon
Dr. Thomas Modine is a renowned surgeon in TAVI, TMVR, minimally invasive surgery, and valve sparing techniques. He is also involved in basic science research programs and in the development of percutaneous mitral devices. His research interests are in aortic valve complex, bioengineering, beating heart surgery, hybrid approaches, TAVI and TMVR. He is currently working as a consultant Cardiac Surgeon at Bordeaux University Hospital in France and as a Professor at Jiao Tong University, Shanghai. He holds an MD, PhD and MBA from Lille University Hospital, France.